BRITANYA FARLEY: Open Payments
NPI 1528252053 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,389 in 64 payments from 18 companies in 2025. Trend: 2023 $1,059 · 2024 $1,428 · 2025 $1,389
Food & beverage: $1,389
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $304 |
| AstraZeneca Pharmaceuticals LP | 13 | $274 |
| Novo Nordisk Inc | 9 | $244 |
| Lilly USA, LLC | 5 | $114 |
| Abbott Laboratories | 3 | $65 |
| Amgen Inc. | 3 | $61 |
| Exact Sciences Corporation | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| Boston Scientific Corporation | 1 | $35 |
Products named: QULIPTA, FARXIGA, Ozempic, UBRELVY, AIRSUPRA, MOUNJARO, Wegovy, FREESTYLE LIBRE 3.
Industry payments across VA — which companies pay providers there.
